1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy

por Banna, G.L., Cantale, O., Friedlaender, A., Addeo, A.
Publicado 2020